Advertisement
Screener

TENAX THERAPEUTICS, INC. (TENX) Notes Payable

2.8 / 5 stars · 68/120 Roast Me

TENAX THERAPEUTICS, INC. Notes Payable

TENAX THERAPEUTICS, INC. (TENX) had Notes Payable of $624.30 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.

Discontinued › Balance Sheet › Liabilities

us-gaap:NotesPayable · last filed 2023-11-13

  • 2023-09-30: Notes Payable $624.30K.
  • 2022-12-31: Notes Payable $624.30K.
  • 2021-12-31: Notes Payable $0.00.
  • 2021-09-30: Notes Payable $0.00.
Period endNotes Payable
2023-09-30$624.30K
10-Q · filed 2023-11-13
2022-12-31$624.30K
10-K · filed 2023-03-31
2021-12-31$0.00
10-K · filed 2023-03-31
2021-09-30$0.00
10-Q · filed 2021-11-15
2021-06-30$0.00
10-Q · filed 2021-08-16
2020-12-31$124.17K
10-K · filed 2022-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
OS Therapies Inc (OSTX)United States$0.076B-2.17